Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/1/2000
1.
Phase II Study of Liposomal Tretinoin (Atragen) for Relapsed Acute Promyelocytic Leukemia (Summary Last Modified 03/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
2 and over
Pharmaceutical / Industry
AR-623-41.075-002
MDA-DM-94063, NCI-V95-0679
Last Modified:
10/24/2007
 
First Published:
1/1/1999
2.
Phase II Study of Tretinoin Liposome and Interferon alfa-2b in Patients With Metastatic Renal Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Other
NYWCCC-0498-209
NCI-V98-1490, NCT00003656
Last Modified:
11/1/2001
 
First Published:
7/1/2000
3.
Phase II Study of Tretinoin Liposome in Patients With Recurrent or Refractory Hodgkin's Disease (Summary Last Modified 11/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
12 and over
NCI
MDA-ID-99255
NCI-103, NCT00005969, 103
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute